KI-Beratung Beta

Produktbild: Role of Biomarkers in Cancer Diagnosis and Therapeutics

Role of Biomarkers in Cancer Diagnosis and Therapeutics

184,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.03.2026

Herausgeber

Sushama Talegaonkar + weitere

Verlag

Elsevier Science & Technology

Seitenzahl

684

Maße (L/B/H)

23,6/19,2/3,4 cm

Gewicht

1356 g

Sprache

Englisch

ISBN

978-0-443-44041-0

Beschreibung

Portrait

Dr. Sushama Talegaonkar is an Associate Professor at the Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, India. She has approximately 21 years of experience, and has published more than 220 research papers in high impact international journals. Besides this, she has coauthored 6 books and authored 15 chapters in international reference books. Recently, she received the Professor C. J. Shishoo Award for Best Research. Her research paper titled "Development and bioavailability assessment of ramipril nanoemulsion formulation” has received the most cited research paper award on behalf of Elsevier and the board of European Journal of Pharmaceutics and Biopharmaceutics. She was awarded the prestigious Motan Devi Dandiya Biennial Prize for best publication in Pharmaceutical Sciences for the period 2010-11. Dr. Talegaonkar is actively involved in developing a wide variety of smart and functionalized nanodrug delivery systems for targeted anticancer drug delivery.Lalit Kumar is an Assistant Professor in the Department of Pharmaceutics at the National Institute of Pharmaceutical Education and Research, Hajipur, Vaishali, Bihar, India. His area of research includes the development of nanocarriers for drug-targeting tumor cells in the colon, brain, breast, and lungs.

Dr. Dalapathi Gugulothu working as Assistant professor, Department of Pharmaceutics , Delhi Institute of Pharmaceutical Sciences and Research, Delhi Pharmaceutical Sciences and Research University , New Delhi.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.03.2026

Herausgeber

Verlag

Elsevier Science & Technology

Seitenzahl

684

Maße (L/B/H)

23,6/19,2/3,4 cm

Gewicht

1356 g

Sprache

Englisch

ISBN

978-0-443-44041-0

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben und erhalten Sie dafür eine Thalia Geschenkkarte.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Role of Biomarkers in Cancer Diagnosis and Therapeutics
  • I. Biomarkers in Cancer Diagnosis and Treatment
    1. Prostate-Specific Antigen (PSA)
    2. Carcinoembryonic Antigen (CEA)
    3. Tissue Polypeptide-Specific Antigen (TPS) CA72-4
    4. Carbohydrate Antigen 19-9 (CA19-9)
    5. Carbohydrate Antigen 125 (CA-125)
    6. Carbohydrate Antigen 72-4 (CA72-4)
    7. Aminopeptidase N
    8. Alkaline Phosphatase
    9. CD26/Dipeptidyl Peptidase (DPP)4
    10. Genetic Biomarkers in Cancer
    11. Immunology Biomarkers in Cancer
    12. Microbiome Biomarkers in Cancer
    13. Glycobiology Biomarkers in Cancer
    14. Epigenetic Biomarkers in Cancer

    II. Metabolic Targets and Cancer Therapeutics
    15. Introduction to Metabolic Targets and Autophagy
    16. Glucose Metabolism - Hexokinase-2 (HK2), Lactate Dehydrogenase A (LDHA), Pyruvate Kinase M2 Isoform (PKM2), Pyruvate Dehydrogenase (PDK), Glucose Transporter, Enolase 1 (ENO1), and Monocarboxylate Transporter (MCT1)
    17. Nucleic Acid Metabolism - Folate Cycle, Nucleotide Incorporation (DNA Polymerase/Ribonucleotide Reductase (RNR)), Deoxynucleotide Synthesis (RNR), and Thymidine Synthesis (TYMS)
    18. Amino Acid Metabolism - Arginine and Asparagine, Serine/Threonine Protein Kinase (Glycogen Synthase Kinase-3 (GSK-3))
    19. Glucose and Amino Acid Metabolism - Isocitrate Dehydrogenase-1 (IDH-1)
    20. Glucose, Nucleic Acid, Fatty Acid, and Amino Acid Metabolism - Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH)

    III. Miscellaneous Cancer Therapeutic Approaches
    21. Targeting DNA Repair Pathways - O-6-Methylguanine-DNA Methyltransferase (MGMT), Base Excision Repair, Double Strand Breaks Repair, and mtDNA Repair
    22. Cell Cycle Inhibition - Cyclin-Dependent Kinases (CDKs), and G1 Checkpoint
    23. Topoisomerase-Induced DNA Damage and Therapeutic Potential
    24. Polo-like Kinase 4 (PLK4) Inhibitors in Cancer Therapy
    25. Synthetic Lethality by Poly (ADP-Ribose) Polymerase Inhibitors
    26. Innovative Therapeutic Approaches